The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.

MLA

Karaceper, Maria D., et al. “The Health System Impact of False Positive Newborn Screening Results for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cohort Study.” Orphanet Journal of Rare Diseases, vol. 11, Feb. 2016, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13023-016-0391-5.

APA

Karaceper, M. D., Chakraborty, P., Coyle, D., Wilson, K., Kronick, J. B., Hawken, S., Davies, C., Brownell, M., Dodds, L., Feigenbaum, A., Fell, D. B., Grosse, S. D., Guttmann, A., Laberge, A.-M., Mhanni, A., Miller, F. A., Mitchell, J. J., Nakhla, M., Prasad, C., & Rockman-Greenberg, C. (2016). The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Orphanet Journal of Rare Diseases, 11, 1–9. https://doi.org/10.1186/s13023-016-0391-5

Chicago

Karaceper, Maria D., Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B. Kronick, Steven Hawken, Christine Davies, et al. 2016. “The Health System Impact of False Positive Newborn Screening Results for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cohort Study.” Orphanet Journal of Rare Diseases 11 (February): 1–9. doi:10.1186/s13023-016-0391-5.